eISSN: 2084-9885
ISSN: 1896-6764
Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
1-2/2021
vol. 16
 
Share:
Share:
more
 
 
abstract:
Original paper

Depression and anxiety in patients recently recovered from coronavirus disease (COVID‑19)

Rafał Dankowski
1
,
Wioletta Sacharczuk
1
,
Dominika Duszyńska
1
,
Weronika Mikołajewska
1
,
Anna Szałek-Goralewska
1
,
Anna Łojko-Dankowska
2
,
Andrzej Szyszka
1
,
Dorota Łojko
3

1.
2nd Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland
2.
Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland
3.
Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznań, Poland
Neuropsychiatria i Neuropsychologia 2021; 16, 1–2: 11–16
Online publish date: 2021/07/27
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
To evaluate the presence and severity of anxiety and depressive symptoms in patients who recently recovered from coronavirus disease 2019 (COVID-19).

Material and methods
In this crosssectional observational study, patients who had recovered from COVID-19 were assessed between February and April 2021. The symptoms reported by patients were evaluated using a questionnaire developed by the authors based on the National Institute for Health and Care Excellence (NICE) guidelines. The Beck Depression Inventory (BDI) and the State-Trait Anxiety Inventory (STAI) were used to assess their depressive symptoms and anxiety.

Results
Of the 102 patients, 45 (44%) were men, and the mean age (± standard deviation – SD) was 52 ±13 years. The mean time interval (±SD) between COVID-19 diagnosis and the examination was 56 ±18 days. Seventy-eight (76%) patients were treated at home, while 24 (23.5%) were hospitalized. Fatigue, cognitive impairment (“brain fog”), breathlessness, and cough were the most frequently reported complaints. Median scores of the BDI, state-anxiety (STAI 1) and trait-anxiety (STAI 2) were 7 (interquartile range, IQR = 10), 38 (IQR = 13), and 40.5 (IQR = 14), respectively. Mild depressive symptoms were observed in almost 30% of patients. Women scored significantly higher than men.

Conclusions
Patients who have recently recovered from COVID-19 show increased anxiety and depressive symptoms, the intensity of which was more pronounced in women. From the clinical perspective, physicians should be aware of the anxiety and depressive symptoms of the post-COVID-19 syndrome.

keywords:

COVID-19, BDI, STAI, anxiety, depression

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.